https://www.gilead.com/news/news-details/2003/96-week-data-from-gileads-study-903-show-low-rate-of-virologic-failure-among-patients-taking-viread
96-Week Data from Gilead's Study 903 Show Low Rate of Virologic Failure among Patients Taking Viread
96 Week Data from Gileads Study 903 Show Low Rate of Virologic Failure among Patients Taking Viread
https://www.gilead.com/news/news-details/2004/gilead-reduces-price-of-viread-in-the-developing-world-by-37-percent-anti-hiv-medication-available-to-68-resource-limited-countries-through-the-gilead-access-program
Gilead Reduces Price of Viread in the Developing World by 37 Percent; Anti-HIV Medication Available...
Gilead Reduces Price of Viread in the Developing World by 37 Percent Anti HIV Medication Available to 68 Resource Limited Countries Through the Gilead Access...
https://www.gilead.com/news/news-details/2005/gilead-reduces-prices-for-vireadr-and-truvadar-in-the-developing-world
Gilead Reduces Prices for Viread(R) and Truvada(R) in the Developing World
Gilead Reduces Prices for VireadR and TruvadaR in the Developing World
r and
https://www.advocate.com/health/health-news/2005/02/01/viread-study-runs-opposition-cameroon-14980
Viread study runs into opposition in Cameroon (14980) | Advocate.com
vireadstudyrunsoppositioncameroon
https://worldvectorlogo.com/ar/logo/viread
Viread Vector Logo - Download Free SVG Icon | Worldvectorlogo
Download Viread logo vector in SVG format. This logo is compatible with EPS, AI, PSD and Adobe PDF formats.
vector logodownload freevireadsvgicon
https://www.goodrx.com/compare/truvada-vs-viread
Truvada vs. Viread for HIV Treatment: Important Differences and Potential Risks.
Compare Truvada and Viread side effects, costs and risks for treating HIV Treatment.
hiv treatmenttruvadavsviread
https://www.gilead.com/news/news-details/2006/96-week-data-from-gileads-study-934-comparing-vireadr-and-emtrivar-to-combivirr-both-in-combination-with-sustivar-presented-at-xvi-international-aids-conference
96-Week Data from Gilead's Study 934 Comparing Viread(R) and Emtriva(R) to Combivir(R) Both in...
96 Week Data from Gileads Study 934 Comparing VireadR and EmtrivaR to CombivirR Both in Combination with SustivaR Presented at XVI International AIDS Conference
https://www.advocate.com/health/health-news/2003/08/09/fda-again-orders-gilead-stop-downplaying-vireads-risks-9543
FDA again orders Gilead to stop downplaying Viread's risks (9543) | Advocate.com
https://www.gilead.com/news/news-details/2002/gilead-sciences-announces-second-quarter-2002-financial-results-strong-viread-sales-push-total-revenues-past-100-million-lead-to-profitability
Gilead Sciences Announces Second Quarter 2002 Financial Results; Strong Viread Sales Push Total...
Gilead Sciences Announces Second Quarter 2002 Financial Results Strong Viread Sales Push Total Revenues Past 100 Million Lead to Profitability
https://www.advocate.com/health/health-news/2002/12/19/gilead-make-viread-available-poor-countries-no-profit-7256
Gilead to make Viread available in poor countries at no profit (7256) | Advocate.com
https://www.viread.com/
Viread (tenofovir disoproxil fumarate) | Official Website
VIREAD is indicated for the treatment of chronic (long-lasting) hepatitis B virus (HBV) in people 12 years of age and older. VIREAD will not cure HBV. VIREAD...
tenofovir disoproxil fumaratevireadofficial
https://www.goodrx.com/compare/viread-vs-pegasys
Viread vs. Pegasys for Hepatitis B: Important Differences and Potential Risks.
Compare Viread and Pegasys side effects, costs and risks for treating Hepatitis B.
hepatitis bvireadvspegasys